Pigouvian Tax

A Pigouvian tax is a corrective tax imposed on an activity whose costs spill over to other people. It internalises a negative externality by making consumers face, through a higher price, part or all of the social cost that their consumption otherwise leaves to society. It seeks to change behaviour rather than merely raise revenue.

How internalisation works

Unhealthy goods may be overconsumed because their market price reflects production costs but not all wider health and social costs. Ideally, the tax per unit equals the marginal external cost at the socially desirable level of consumption.

• The tax raises the private cost of consumption towards the social cost, reducing demand and output towards the socially efficient quantity.
• Consumers who continue consuming pay towards the external costs they generate, while producers receive a price signal to reformulate products or shift supply.
• Tax revenue may finance healthcare, prevention or treatment, although revenue use is separate from the tax's corrective price effect.

Application to unhealthy consumption

Potential external costs include publicly financed treatment, harm from second-hand smoke, alcohol-related injuries to others and other burdens imposed on households or society. Taxes may therefore be levied on tobacco, alcohol or sugar-sweetened beverages.

• A well-designed tax base should approximate harm, such as the quantity of tobacco, alcohol or added sugar, rather than relying only on product value.
• Higher prices can complement health warnings and restrictions by discouraging initiation and encouraging reduced consumption or substitution towards less harmful products.
• The consumer's own health loss is primarily a private cost, not an externality; it becomes relevant to corrective policy when addiction, imperfect information or behavioural biases prevent informed choice.

Limits and policy safeguards

Actual external damage is difficult to measure, and harms vary across products and users. A uniform rate may therefore under-tax some products and over-tax others.

• Demand may respond weakly where consumption is addictive, so taxation alone cannot address the problem.
• High rates can encourage illicit trade or substitution towards other harmful goods unless administration and product coverage are effective.
• The payment burden may fall disproportionately on low-income consumers; targeted health spending and cessation support can reduce this equity concern.
• Regulation, public information, labelling, treatment and restrictions on harmful exposure remain necessary complements.

How UPSC asks this